VSY Biotechnology BV and Carl Zeiss Meditec AG settled their legal disputes

Friday, February 15, 2019

Comments

VSY Biotechnology BV and Carl Zeiss Meditec AG settled their legal disputes

VSY Biotechnology BV and Carl Zeiss Meditec AG jointly announced that both companies resolved their legal and patent disputes with respect to Tri-ED 611. The companies agreed not to disclose the terms of the settlement.

Source: VSY Viotechnology BV

Which of the following is NOT a typical sign of thyroid eye disease?
1. proptosis
2. ptosis
3. lid retraction
4. lid lag
Check The Answer

CV-5000S Computerized Vision Tester
The CV-5000S Computerized Vision Tester ... view product
CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

VSY Biotechnology BV and Carl Zeiss Meditec AG settled their legal disputes

Comments

Quick Quiz

Which of the following is NOT a typical sign of thyroid eye disease?

AdGlare RMR Ad

Featured Products

CV-5000S Computerized Vision Tester

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us